Research progress in the mechanism and treatment of retinal ischemia reperfusion injury_Chinese Journal of Ocular Fundus Diseases

Authors：

Guo Miao ,  Yan Hua

Department of Ophtalmology, Tianjin Medical University General Hospital, Tianjin 300052, China;

Corresponding author：

Yan Hua, Email: zyyyanhua@tmu.edu.cn

Keywords：

Reperfusion injury/etiology; Reperfusion injury/therapy; Review

DOI：

10.3760/cma.j.cn511434-20180807-00276

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Retinal ischemia-reperfusion injury (RIRI) is an important pathophysiological basis of diabetic retinopathy, glaucoma, central retinal arteriovenous obstruction and some other ischemic retinal diseases. At present, there are several theories about the pathogenesis of RIRI, which included oxidative stress, apoptosis, necrosis, necroptosis, vascular injury and inflammatory reaction. Aim at the above pathogenesis of RIRI, domestic and foreign scholars have put forward a lot of methods in treating RIRI, including anti-radical damage, anti-glutamic acid excitotoxicity, anti-apoptosis, anti-necrosis, anti-necroptosis, protection of tight junctions, protection of endothelial cells, anti-inflammatory response, etc. Although there are a lot of drug research on RIRI, the timing of drug interventions for RIRI is still unclear. It may achieve twice the result with half the effort to determine the most effective treatment time window, and will also play a vital guiding role in the clinical treatment of ophthalmic related diseases.

Citation： Guo Miao, Yan Hua. Research progress in the mechanism and treatment of retinal ischemia reperfusion injury. Chinese Journal of Ocular Fundus Diseases, 2020, 36(6): 483-488. doi: 10.3760/cma.j.cn511434-20180807-00276 Copy

1.	Pan H, He M, Liu R, et al. Sulforaphane protects rodent retinas against ischemia-reperfusion injury through the activation of the Nrf2/HO-1 antioxidant pathway[J/OL]. PLoS One, 2014, 9(12): 114186[2014-12-03]. http://europepmc.org/abstract/MED/25470382. DOI: 10.1371/journal.pone.0114186.
2.	Gao S, Andreeva K, Cooper NG. Ischemia-reperfusion injury of the retina is linked to necroptosis via the ERK1/2-RIP3 pathway[J]. Mol Vis, 2014, 20: 1374-1387.
3.	Minhas G, Sharma J, Khan N. Cellular stress response and immune signaling in retinal ischemia-reperfusion injury[J/OL]. Front Immunol, 2016, 7: 444[2016-10-24]. http://europepmc.org/article/MED/27822213. DOI: 10.3389/fimmu.2016.00444.
4.	Dvoriantchikova G, Barakat D, Brambilla R, et al. Inactivation of astroglial NF-κB promotes survival of retinal neurons following ischemic injury[J]. Eur J Neurosci, 2009, 30(2): 175-185. DOI: 10.1111/j.1460-9568.2009.06814.x.
5.	Barakat DJ, Dvoriantchikova G, Ivanov DV, et al. Astroglial NF-κB mediates oxidative stress by regulation of NADPH oxidase in a model of retinal ischemia reperfusion injury[J/OL]. J Neurochem, 2012, 120(4): 586597[2012-01-04]. http://europepmc.org/article/PMC/3310387. DOI: 10.1111/j.1471-4159.2011.07595.x.
6.	Chen Y, Huang Y, Chen J, et al. Protective effects of glucosamine on oxidative-stress and ischemia/reperfusion-induced retinal injury[J]. Invest Ophthalmol Vis Sci, 2015, 56(3): 1506-1516. DOI: 10.1167/iovs.14-15726.
7.	Ishizuka F, Shimazawa M, Umigai N, et al. Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice[J]. Eur J Pharmacol, 2013, 703(1): 1-10. DOI: 10.1016/j.ejphar.2013.02.007.
8.	Swanson RA, Ying W, Kauppinen TM, et al. Astrocyte influences on ischemic neuronal death[J]. Curr Mol Med, 2004, 4(2): 193-205. DOI: 10.2174/1566524043479185.
9.	Lan A, Liao X, Mo L, et al. Hydrogen sulfide protects against chemical hypoxia-induced injury by inhibiting ROS-activated ERK1/2 and p38MAPK signaling pathways in PC12 cells[J/OL]. PLoS One, 2011, 6(10): 25921[2011-10-05]. http://europepmc.org/article/PMC/3187826. DOI: 10.1371/journal.pone.0025921.
10.	Xu Z, Cho H, Hartsock MJ, et al. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion[J]. J Neurochem, 2015, 133(2): 233-241. DOI: 10.1111/jnc.13064.
11.	Wei Y, Gong J, Yoshida T, et al. Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury[J]. Free Radic Biol Med, 2011, 51(1): 216-224. DOI: 10.1016/j.freeradbiomed.2011.04.026.
12.	Himori N, Yamamoto K, Maruyama K, et al. Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death[J]. J Neurochem, 2013, 127(5): 669-680. DOI: 10.1111/jnc.12325.
13.	Lee D, Kim K, Noh YH, et al. Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury[J/OL]. PLoS One, 2012, 7(10): 47098[2012-10-09]. http://europepmc.org/article/PMC/3467218. DOI: 10.1371/journal.pone.0047098.
14.	Fukuda K, Hirooka K, Mizote M, et al. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin Ⅱ type 1 receptor[J]. Invest Ophthalmol Vis Sci, 2010, 51(7): 3629-3638. DOI: 10.1167/iovs.09-4107.
15.	Fujita T, Hirooka K, Nakamura T, et al. Neuroprotective effects of angiotensin Ⅱ type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels[J]. Invest Ophthalmol Vis Sci, 2012, 53(7): 4099-4110. DOI: 10.1167/iovs.11-9167.
16.	Arikan S, Ersan I, Karaca T, et al. Quercetin protects the retina by reducing apoptosis due to ischemia-reperfusion injury in a rat model[J]. Arq Bras Oftalmol, 2015, 78(2): 100-104. DOI: 10.5935/0004-2749.20150026.
17.	Gencer B, Karaca T, Tufan HA, et al. The protective effects of dexmedetomidine against apoptosis in retinal ischemia/reperfusion injury in rats[J]. Cutan Ocul Toxicol, 2014, 33(4): 283-288. DOI: 10.3109/15569527.2013.857677.
18.	Zhang Y, Zhang Z, Yan H, et al. Simvastatin inhibits ischemia/reperfusion injury-induced apoptosis of retinal cells via downregulation of the tumor necrosis factor-α/nuclear factor-κB pathway[J]. Int J Mol Med, 2015, 36(2): 399-405. DOI: 10.3892/ijmm.2015.2244.
19.	Zhang Z, Qin X, Tong N, et al. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation[J]. Exp Eye Res, 2012, 94(1): 98-108. DOI: 10.1016/j.exer.2011.11.013.
20.	Chen Q, Wang H, Liao S, et al. Nerve growth factor protects retinal ganglion cells against injury induced by retinal ischemia-reperfusion in rats[J]. Growth Factors, 2015, 33(2): 149-159. DOI: 10.3109/08977194.2015.1010642.
21.	Shima C, Adachi Y, Minamino K, et al. Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina[J]. Ophthalmic Res, 2012, 48(4): 199-207. DOI: 10.1159/000340059.
22.	Qi Y, Chen L, Zhang L, et al. Crocin prevents retinal ischaemia/reperfusion injury-induced apoptosis in retinal ganglion cells through the PI3K/AKT signalling pathway[J]. Exp Eye Res, 2013, 107: 44-51. DOI: 10.1016/j.exer.2012.11.011.
23.	Wu J, Wang R, Yang D, et al. Hydrogen postconditioning promotes survival of rat retinal ganglion cells against ischemia/reperfusion injury through the PI3K/Akt pathway[J]. Biochem Biophys Res Commun, 2018, 495(4): 2462-2468. DOI: 10.1016/j.bbrc.2017.12.146.
24.	Zhang SX, Sanders E, Fliesler SJ, et al. Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration[J]. Exp Eye Res, 2014, 125: 30-40. DOI: 10.1111/febs.14522.
25.	Jing G, Wang JJ, Zhang SX, et al. ER stress and apoptosis: a new mechanism for retinal cell death[J/OL]. Exp Diabetes Res, 2012, 2012: 589589[2011-12-14]. http://europepmc.org/article/PMC/3246718. DOI: 10.1002/jcp.28100.
26.	Zhang Z, Tong N, Gong Y, et al. Valproate protects the retina from endoplasmic reticulum stress-induced apoptosis after ischemia-reperfusion injury[J]. Neurosci Lett, 2011, 504(2): 88-92. DOI: 10.1016/j.neulet.2011.09.003.
27.	Rosenbaum DM, Degterev A, David J, et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model[J]. J Neurosci Res, 2010, 88(7): 1569-1576. DOI: 10.1002/jnr.22314.
28.	Kim CR, Kim JH, Park HL, et al. Ischemia reperfusion injury triggers TNFα induced-necroptosis in rat retina[J]. Curr Eye Res, 2017, 42(5): 771-779. DOI: 10.1080/02713683.2016.1227449.
29.	Dvoriantchikova G, Degterev A, Ivanov DV, et al. Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage[J]. Exp Eye Res, 2014, 123: 1-7. DOI: 10.1016/j.exer.2014.04.009.
30.	Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation[J]. Nature, 2015, 517(7534): 311-320. DOI: 10.1038/nature14191.
31.	Kaczmarek A, Vandenabeele P, Krysko DV, et al. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance[J]. Immunity, 2013, 38(2): 209-223. DOI: 10.1016/j.immuni.2013.02.003.
32.	Daneshmeyer HV, Kerr NM, Zhang J, et al. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia[J]. Brain, 2012, 135(2): 506-520. DOI: 10.1093/brain/awr338.
33.	Kerr NM, Johnson CS, Zhang J, et al. High pressure-induced retinal ischaemia reperfusion causes upregulation of gap junction protein connexin43 prior to retinal ganglion cell loss[J]. Exp Neurol, 2012, 234(1): 144-152. DOI: 10.1016/j.expneurol.2011.12.027.
34.	Danesh-Meyer HV, Zhang J, Acosta ML, et al. Connexin43 in retinal injury and disease[J]. Prog Retin Eye Res, 2016, 51: 41-68. DOI: 10.1016/j.preteyeres.2015.09.004.
35.	Kim JH, Kim JH, Lee YM, et al. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation[J]. J Cereb Blood Flow Metab, 2009, 29(9): 1559-1567. DOI: 10.1038/jcbfm.2009.78.
36.	Hosoya K, Tachikawa M. The inner blood-retinal barrier: molecular structure and transport biology[J]. Adv Exp Med Biol, 2012, 763: 85-104.
37.	Muthusamy A, Lin C, Shanmugam S, et al. Ischemia–reperfusion injury induces occludin phosphorylation/ubiquitination and retinal vascular permeability in a VEGFR-2-dependent manner[J]. J Cereb Blood Flow Metab, 2014, 34(3): 522-531. DOI: 10.1038/jcbfm.2013.230.
38.	Brankin B, Campbell M, Canning P, et al. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium[J]. Exp Eye Res, 2005, 81(1): 22-31. DOI: 10.1016/j.exer.2005.01.005.
39.	Tong N, Zhang Z, Zhang W, et al. Diosmin alleviates retinal edema by protecting the blood-retinal barrier and reducing retinal vascular permeability during ischemia/reperfusion injury[J/OL]. PLoS One, 2013, 8(4): 61794[2013-04-24]. http://europepmc.org/article/PMC/3634841. DOI: 10.1371/journal.pone.0061794.
40.	Nakahara T, Hoshino M, Hoshino S, et al. Structural and functional changes in retinal vasculature induced by retinal ischemia-reperfusion in rats[J]. Exp Eye Res, 2015, 135: 134-145. DOI: 10.1016/j.exer.2015.02.020.
41.	Shosha E, Xu Z, Yokota H, et al. Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury[J/OL]. Cell Death Dis, 2016, 7(11): 2483[2016-11-24]. https://europepmc.org/article/PMC/5260867. DOI: 10.1038/cddis.2016.295.
42.	Liu L, Jiang Y, Steinle JJ, et al. Inhibition of HMGB1 protects the retina from ischemia-reperfusion, as well as reduces insulin resistance proteins[J/OL]. PLoS One, 2017, 12(5): 0178236[2017-05-23]. http://europepmc.org/article/PMC/5441648. DOI: 10.1371/journal.pone.0178236.
43.	Liu L, Jiang Y, Steinle JJ, et al. Compound 49b Restores retinal thickness and reduces degenerate capillaries in the rat retina following ischemia/reperfusion[J/OL]. PLoS One, 2016, 11(7): 0159532[2016-07-20]. http://europepmc.org/abstract/MED/27439004. DOI: 10.1371/journal.pone.0159532.
44.	Goncalves A, Lin C, Muthusamy A, et al. Protective effect of a GLP-1 analog on ischemia-reperfusion induced blood-retinal barrier breakdown and inflammation[J]. Invest Ophthalmol Vis Sci, 2016, 57(6): 2584-2592. DOI: 10.1167/iovs.15-19006.
45.	Fang I, Yang C, Yang C, et al. Chitosan oligosaccharides prevented retinal ischemia and reperfusion injury via reduced oxidative stress and inflammation in rats[J]. Exp Eye Res, 2015, 130: 38-50. DOI: 10.1016/j.exer.2014.12.001.
46.	Wang J, Sun Z, Shen J, et al. Octreotide protects the mouse retina against ischemic reperfusion injury through regulation of antioxidation and activation of NF-κB[J/OL]. Oxid Med Cell Longev, 2015, 2015: 970156[2015-06-14]. http://europepmc.org/article/PMC/4484568. DOI: 10.1155/2015/970156.
47.	Zhang X, Xiao Y, Zhang Y, et al. Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats[J]. Invest Ophthalmol Vis Sci, 2013, 54(6): 3912-3921. DOI: 10.1167/iovs.13-11614.
48.	Zhang Y, Wang R, Li W, et al. Pioglitazone ameliorates retinal ischemia/reperfusion injury via suppressing NLRP3 inflammasome activities[J]. Int J Ophthalmol, 2017, 10(12): 1812-1818. DOI: 10.18240/ijo.2017.12.04.
49.	Fang I, Yang C, Yang C, et al. Chitosan oligosaccharides attenuates oxidative-stress related retinal degeneration in rats[J/OL]. PLoS One, 2013, 8(10): 77323[2013-10-14]. http://europepmc.org/article/PMC/3796472. DOI: 10.1371/journal.pone.0077323.
50.	He M, Pan H, Chang RC, et al. Activation of the Nrf2/HO-1 antioxidant pathway contributes to the protective effects of lycium barbarum polysaccharides in the rodent retina after ischemia-reperfusion-induced damage[J/OL]. PLoS One, 2014, 9(1): 84800[2014-01-06]. http://europepmc.org/article/PMC/3882254. DOI: 10.1371/journal.pone.0084800.
51.	Liu L, Sun Q, Wang R, et al. Methane attenuates retinal ischemia/reperfusion injury via anti-oxidative and anti-apoptotic pathways[J]. Brain Res, 2016, 1646: 327-333. DOI: 10.1016/j.brainres.2016.05.037.
52.	Liu Y, Tang L, Chen B, et al. Effects of antioxidant gene therapy on retinal neurons and oxidative stress in a model of retinal ischemia/reperfusion[J]. Free Radic Biol Med, 2012, 52(5): 909-915. DOI: 10.1016/j.freeradbiomed.2011.12.013.
53.	Zhang X, Tohari AM, Marcheggiani F, et al. Therapeutic potential of co-enzyme Q10 in retinal diseases[J]. Curr Med Chem, 2017, 24(39): 4329-4339. DOI: 10.2174/0929867324666170801100516.
54.	Lee D, Kim K, Shim MS, et al. Coenzyme Q10 ameliorates oxidative stress and prevents mitochondrial alteration in ischemic retinal injury[J]. Apoptosis, 2014, 19(4): 603-614. DOI: 10.1007/s10495-013-0956-x.
55.	Lee D, Shim M S, Kim K, et al. Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma[J]. Invest Ophthalmol Vis Sci, 2014, 55(2): 993-1005. DOI: 10.1167/iovs.13-12564.
56.	张玉, 颜华. 辛伐他汀对大鼠视网膜缺血再灌注中Bcl-2和Bax表达及细胞凋亡的影响[J]. 中华眼科杂志, 2014, 50(11): 826-832. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.006.Zhang Y, Yan H. Effect of simvastatin on retinal Bcl-2/Bax expression and cell apoptosis in rats with ischemia-reperfusion injury[J]. Chin J Ophthalmol, 2014, 50(11): 826-832. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.006.
57.	彭亚力, 胡敏, 孔蕾, 等. 特异性阻断剂Nec-1对视网膜缺血再灌注损伤模型小鼠坏死性凋亡的影响及作用[J]. 眼科新进展, 2017, 37(10): 914-917, 921. DOI: 10.13389/j.cnki.rao.2017.0232.Peng YL, Hu M, Kong L, et al. The impact and effect of specific blocker Nec-1 on necroptosis of retinal ischemia-reperfusion injury in a mouse model[J]. Rec Adv Ophthalmol, 2017, 37(10): 914-917, 921. DOI: 10.13389/j.cnki.rao.2017.0232.
58.	Kohen MC, Tatlipinar S, Cumbul A, et al. The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury[J]. Mol Vis, 2018, 24: 239-250.
59.	Abcouwer SF, Lin C, Shanmugam S, et al. Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury[J]. J Neuroinflammation, 2013, 10(1): 149. DOI: 10.1186/1742-2094-10-149.
60.	Mi X, Feng Q, Lo AC, et al. Protection of retinal ganglion cells and retinal vasculature by lycium barbarum polysaccharides in a mouse model of acute ocular hypertension[J/OL]. PLoS One, 2012, 7(10): 45469[2012-10-19]. http://europepmc.org/article/PMC/3477168. DOI: 10.1371/journal.pone.0045469.
61.	张惟, 韩琪, 颜华, 等. 糖尿病视网膜病变大鼠骨髓内皮祖细胞数量和功能变化[J]. 中华眼视光学与视觉科学杂志, 2013, 15(2): 92-97. DOI: 10.3760/cma.j.issn.1674-845X.2013.02.008.Zhang W, Han Q, Yan H, et al. Changes in the number and function of bone marrow endothelial progenitor cells in diabetic retinopathy rats[J]. Chin J Ophthalmol Vis Sci, 2013, 15(2): 92-97. DOI: 10.3760/cma.j.issn.1674-845X.2013.02.008.
62.	Li S, Fung FK, Fu Z, et al. Anti-inflammatory effects of lutein inretinal ischemic/hypoxic injury: in vivo and in vitro studies[J]. Invest Ophthalmol Vis Sci, 2012, 53(10): 5976-5984. DOI: 10.1167/iovs.12-10007.
63.	张海江, 梁亮. 姜黄素对视网膜缺血再灌注损伤大鼠视网膜组织结构及IL-23和IL-17表达的影响[J]. 国际眼科杂志, 2017, 17(8): 1423-1426. DOI: 10.3980/j.issn.1672-5123.2017.8.08.Zhang HJ, Liang L. Effects of curcumin on retinal tissue structure and IL-23 and IL-17 expression in rats with retinal ischemia-reperfusion injury[J]. Int Eye Sci, 2017, 17(8): 1423-1426. DOI: 10.3980/j.issn.1672-5123.2017.8.08.

1. Pan H, He M, Liu R, et al. Sulforaphane protects rodent retinas against ischemia-reperfusion injury through the activation of the Nrf2/HO-1 antioxidant pathway[J/OL]. PLoS One, 2014, 9(12): 114186[2014-12-03]. http://europepmc.org/abstract/MED/25470382. DOI: 10.1371/journal.pone.0114186.
2. Gao S, Andreeva K, Cooper NG. Ischemia-reperfusion injury of the retina is linked to necroptosis via the ERK1/2-RIP3 pathway[J]. Mol Vis, 2014, 20: 1374-1387.
3. Minhas G, Sharma J, Khan N. Cellular stress response and immune signaling in retinal ischemia-reperfusion injury[J/OL]. Front Immunol, 2016, 7: 444[2016-10-24]. http://europepmc.org/article/MED/27822213. DOI: 10.3389/fimmu.2016.00444.
4. Dvoriantchikova G, Barakat D, Brambilla R, et al. Inactivation of astroglial NF-κB promotes survival of retinal neurons following ischemic injury[J]. Eur J Neurosci, 2009, 30(2): 175-185. DOI: 10.1111/j.1460-9568.2009.06814.x.
5. Barakat DJ, Dvoriantchikova G, Ivanov DV, et al. Astroglial NF-κB mediates oxidative stress by regulation of NADPH oxidase in a model of retinal ischemia reperfusion injury[J/OL]. J Neurochem, 2012, 120(4): 586597[2012-01-04]. http://europepmc.org/article/PMC/3310387. DOI: 10.1111/j.1471-4159.2011.07595.x.
6. Chen Y, Huang Y, Chen J, et al. Protective effects of glucosamine on oxidative-stress and ischemia/reperfusion-induced retinal injury[J]. Invest Ophthalmol Vis Sci, 2015, 56(3): 1506-1516. DOI: 10.1167/iovs.14-15726.
7. Ishizuka F, Shimazawa M, Umigai N, et al. Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice[J]. Eur J Pharmacol, 2013, 703(1): 1-10. DOI: 10.1016/j.ejphar.2013.02.007.
8. Swanson RA, Ying W, Kauppinen TM, et al. Astrocyte influences on ischemic neuronal death[J]. Curr Mol Med, 2004, 4(2): 193-205. DOI: 10.2174/1566524043479185.
9. Lan A, Liao X, Mo L, et al. Hydrogen sulfide protects against chemical hypoxia-induced injury by inhibiting ROS-activated ERK1/2 and p38MAPK signaling pathways in PC12 cells[J/OL]. PLoS One, 2011, 6(10): 25921[2011-10-05]. http://europepmc.org/article/PMC/3187826. DOI: 10.1371/journal.pone.0025921.
10. Xu Z, Cho H, Hartsock MJ, et al. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion[J]. J Neurochem, 2015, 133(2): 233-241. DOI: 10.1111/jnc.13064.
11. Wei Y, Gong J, Yoshida T, et al. Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury[J]. Free Radic Biol Med, 2011, 51(1): 216-224. DOI: 10.1016/j.freeradbiomed.2011.04.026.
12. Himori N, Yamamoto K, Maruyama K, et al. Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death[J]. J Neurochem, 2013, 127(5): 669-680. DOI: 10.1111/jnc.12325.
13. Lee D, Kim K, Noh YH, et al. Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury[J/OL]. PLoS One, 2012, 7(10): 47098[2012-10-09]. http://europepmc.org/article/PMC/3467218. DOI: 10.1371/journal.pone.0047098.
14. Fukuda K, Hirooka K, Mizote M, et al. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin Ⅱ type 1 receptor[J]. Invest Ophthalmol Vis Sci, 2010, 51(7): 3629-3638. DOI: 10.1167/iovs.09-4107.
15. Fujita T, Hirooka K, Nakamura T, et al. Neuroprotective effects of angiotensin Ⅱ type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels[J]. Invest Ophthalmol Vis Sci, 2012, 53(7): 4099-4110. DOI: 10.1167/iovs.11-9167.
16. Arikan S, Ersan I, Karaca T, et al. Quercetin protects the retina by reducing apoptosis due to ischemia-reperfusion injury in a rat model[J]. Arq Bras Oftalmol, 2015, 78(2): 100-104. DOI: 10.5935/0004-2749.20150026.
17. Gencer B, Karaca T, Tufan HA, et al. The protective effects of dexmedetomidine against apoptosis in retinal ischemia/reperfusion injury in rats[J]. Cutan Ocul Toxicol, 2014, 33(4): 283-288. DOI: 10.3109/15569527.2013.857677.
18. Zhang Y, Zhang Z, Yan H, et al. Simvastatin inhibits ischemia/reperfusion injury-induced apoptosis of retinal cells via downregulation of the tumor necrosis factor-α/nuclear factor-κB pathway[J]. Int J Mol Med, 2015, 36(2): 399-405. DOI: 10.3892/ijmm.2015.2244.
19. Zhang Z, Qin X, Tong N, et al. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation[J]. Exp Eye Res, 2012, 94(1): 98-108. DOI: 10.1016/j.exer.2011.11.013.
20. Chen Q, Wang H, Liao S, et al. Nerve growth factor protects retinal ganglion cells against injury induced by retinal ischemia-reperfusion in rats[J]. Growth Factors, 2015, 33(2): 149-159. DOI: 10.3109/08977194.2015.1010642.
21. Shima C, Adachi Y, Minamino K, et al. Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina[J]. Ophthalmic Res, 2012, 48(4): 199-207. DOI: 10.1159/000340059.
22. Qi Y, Chen L, Zhang L, et al. Crocin prevents retinal ischaemia/reperfusion injury-induced apoptosis in retinal ganglion cells through the PI3K/AKT signalling pathway[J]. Exp Eye Res, 2013, 107: 44-51. DOI: 10.1016/j.exer.2012.11.011.
23. Wu J, Wang R, Yang D, et al. Hydrogen postconditioning promotes survival of rat retinal ganglion cells against ischemia/reperfusion injury through the PI3K/Akt pathway[J]. Biochem Biophys Res Commun, 2018, 495(4): 2462-2468. DOI: 10.1016/j.bbrc.2017.12.146.
24. Zhang SX, Sanders E, Fliesler SJ, et al. Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration[J]. Exp Eye Res, 2014, 125: 30-40. DOI: 10.1111/febs.14522.
25. Jing G, Wang JJ, Zhang SX, et al. ER stress and apoptosis: a new mechanism for retinal cell death[J/OL]. Exp Diabetes Res, 2012, 2012: 589589[2011-12-14]. http://europepmc.org/article/PMC/3246718. DOI: 10.1002/jcp.28100.
26. Zhang Z, Tong N, Gong Y, et al. Valproate protects the retina from endoplasmic reticulum stress-induced apoptosis after ischemia-reperfusion injury[J]. Neurosci Lett, 2011, 504(2): 88-92. DOI: 10.1016/j.neulet.2011.09.003.
27. Rosenbaum DM, Degterev A, David J, et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model[J]. J Neurosci Res, 2010, 88(7): 1569-1576. DOI: 10.1002/jnr.22314.
28. Kim CR, Kim JH, Park HL, et al. Ischemia reperfusion injury triggers TNFα induced-necroptosis in rat retina[J]. Curr Eye Res, 2017, 42(5): 771-779. DOI: 10.1080/02713683.2016.1227449.
29. Dvoriantchikova G, Degterev A, Ivanov DV, et al. Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage[J]. Exp Eye Res, 2014, 123: 1-7. DOI: 10.1016/j.exer.2014.04.009.
30. Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation[J]. Nature, 2015, 517(7534): 311-320. DOI: 10.1038/nature14191.
31. Kaczmarek A, Vandenabeele P, Krysko DV, et al. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance[J]. Immunity, 2013, 38(2): 209-223. DOI: 10.1016/j.immuni.2013.02.003.
32. Daneshmeyer HV, Kerr NM, Zhang J, et al. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia[J]. Brain, 2012, 135(2): 506-520. DOI: 10.1093/brain/awr338.
33. Kerr NM, Johnson CS, Zhang J, et al. High pressure-induced retinal ischaemia reperfusion causes upregulation of gap junction protein connexin43 prior to retinal ganglion cell loss[J]. Exp Neurol, 2012, 234(1): 144-152. DOI: 10.1016/j.expneurol.2011.12.027.
34. Danesh-Meyer HV, Zhang J, Acosta ML, et al. Connexin43 in retinal injury and disease[J]. Prog Retin Eye Res, 2016, 51: 41-68. DOI: 10.1016/j.preteyeres.2015.09.004.
35. Kim JH, Kim JH, Lee YM, et al. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation[J]. J Cereb Blood Flow Metab, 2009, 29(9): 1559-1567. DOI: 10.1038/jcbfm.2009.78.
36. Hosoya K, Tachikawa M. The inner blood-retinal barrier: molecular structure and transport biology[J]. Adv Exp Med Biol, 2012, 763: 85-104.
37. Muthusamy A, Lin C, Shanmugam S, et al. Ischemia–reperfusion injury induces occludin phosphorylation/ubiquitination and retinal vascular permeability in a VEGFR-2-dependent manner[J]. J Cereb Blood Flow Metab, 2014, 34(3): 522-531. DOI: 10.1038/jcbfm.2013.230.
38. Brankin B, Campbell M, Canning P, et al. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium[J]. Exp Eye Res, 2005, 81(1): 22-31. DOI: 10.1016/j.exer.2005.01.005.
39. Tong N, Zhang Z, Zhang W, et al. Diosmin alleviates retinal edema by protecting the blood-retinal barrier and reducing retinal vascular permeability during ischemia/reperfusion injury[J/OL]. PLoS One, 2013, 8(4): 61794[2013-04-24]. http://europepmc.org/article/PMC/3634841. DOI: 10.1371/journal.pone.0061794.
40. Nakahara T, Hoshino M, Hoshino S, et al. Structural and functional changes in retinal vasculature induced by retinal ischemia-reperfusion in rats[J]. Exp Eye Res, 2015, 135: 134-145. DOI: 10.1016/j.exer.2015.02.020.
41. Shosha E, Xu Z, Yokota H, et al. Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury[J/OL]. Cell Death Dis, 2016, 7(11): 2483[2016-11-24]. https://europepmc.org/article/PMC/5260867. DOI: 10.1038/cddis.2016.295.
42. Liu L, Jiang Y, Steinle JJ, et al. Inhibition of HMGB1 protects the retina from ischemia-reperfusion, as well as reduces insulin resistance proteins[J/OL]. PLoS One, 2017, 12(5): 0178236[2017-05-23]. http://europepmc.org/article/PMC/5441648. DOI: 10.1371/journal.pone.0178236.
43. Liu L, Jiang Y, Steinle JJ, et al. Compound 49b Restores retinal thickness and reduces degenerate capillaries in the rat retina following ischemia/reperfusion[J/OL]. PLoS One, 2016, 11(7): 0159532[2016-07-20]. http://europepmc.org/abstract/MED/27439004. DOI: 10.1371/journal.pone.0159532.
44. Goncalves A, Lin C, Muthusamy A, et al. Protective effect of a GLP-1 analog on ischemia-reperfusion induced blood-retinal barrier breakdown and inflammation[J]. Invest Ophthalmol Vis Sci, 2016, 57(6): 2584-2592. DOI: 10.1167/iovs.15-19006.
45. Fang I, Yang C, Yang C, et al. Chitosan oligosaccharides prevented retinal ischemia and reperfusion injury via reduced oxidative stress and inflammation in rats[J]. Exp Eye Res, 2015, 130: 38-50. DOI: 10.1016/j.exer.2014.12.001.
46. Wang J, Sun Z, Shen J, et al. Octreotide protects the mouse retina against ischemic reperfusion injury through regulation of antioxidation and activation of NF-κB[J/OL]. Oxid Med Cell Longev, 2015, 2015: 970156[2015-06-14]. http://europepmc.org/article/PMC/4484568. DOI: 10.1155/2015/970156.
47. Zhang X, Xiao Y, Zhang Y, et al. Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats[J]. Invest Ophthalmol Vis Sci, 2013, 54(6): 3912-3921. DOI: 10.1167/iovs.13-11614.
48. Zhang Y, Wang R, Li W, et al. Pioglitazone ameliorates retinal ischemia/reperfusion injury via suppressing NLRP3 inflammasome activities[J]. Int J Ophthalmol, 2017, 10(12): 1812-1818. DOI: 10.18240/ijo.2017.12.04.
49. Fang I, Yang C, Yang C, et al. Chitosan oligosaccharides attenuates oxidative-stress related retinal degeneration in rats[J/OL]. PLoS One, 2013, 8(10): 77323[2013-10-14]. http://europepmc.org/article/PMC/3796472. DOI: 10.1371/journal.pone.0077323.
50. He M, Pan H, Chang RC, et al. Activation of the Nrf2/HO-1 antioxidant pathway contributes to the protective effects of lycium barbarum polysaccharides in the rodent retina after ischemia-reperfusion-induced damage[J/OL]. PLoS One, 2014, 9(1): 84800[2014-01-06]. http://europepmc.org/article/PMC/3882254. DOI: 10.1371/journal.pone.0084800.
51. Liu L, Sun Q, Wang R, et al. Methane attenuates retinal ischemia/reperfusion injury via anti-oxidative and anti-apoptotic pathways[J]. Brain Res, 2016, 1646: 327-333. DOI: 10.1016/j.brainres.2016.05.037.
52. Liu Y, Tang L, Chen B, et al. Effects of antioxidant gene therapy on retinal neurons and oxidative stress in a model of retinal ischemia/reperfusion[J]. Free Radic Biol Med, 2012, 52(5): 909-915. DOI: 10.1016/j.freeradbiomed.2011.12.013.
53. Zhang X, Tohari AM, Marcheggiani F, et al. Therapeutic potential of co-enzyme Q10 in retinal diseases[J]. Curr Med Chem, 2017, 24(39): 4329-4339. DOI: 10.2174/0929867324666170801100516.
54. Lee D, Kim K, Shim MS, et al. Coenzyme Q10 ameliorates oxidative stress and prevents mitochondrial alteration in ischemic retinal injury[J]. Apoptosis, 2014, 19(4): 603-614. DOI: 10.1007/s10495-013-0956-x.
55. Lee D, Shim M S, Kim K, et al. Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma[J]. Invest Ophthalmol Vis Sci, 2014, 55(2): 993-1005. DOI: 10.1167/iovs.13-12564.
56. 张玉, 颜华. 辛伐他汀对大鼠视网膜缺血再灌注中Bcl-2和Bax表达及细胞凋亡的影响[J]. 中华眼科杂志, 2014, 50(11): 826-832. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.006.Zhang Y, Yan H. Effect of simvastatin on retinal Bcl-2/Bax expression and cell apoptosis in rats with ischemia-reperfusion injury[J]. Chin J Ophthalmol, 2014, 50(11): 826-832. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.006.
57. 彭亚力, 胡敏, 孔蕾, 等. 特异性阻断剂Nec-1对视网膜缺血再灌注损伤模型小鼠坏死性凋亡的影响及作用[J]. 眼科新进展, 2017, 37(10): 914-917, 921. DOI: 10.13389/j.cnki.rao.2017.0232.Peng YL, Hu M, Kong L, et al. The impact and effect of specific blocker Nec-1 on necroptosis of retinal ischemia-reperfusion injury in a mouse model[J]. Rec Adv Ophthalmol, 2017, 37(10): 914-917, 921. DOI: 10.13389/j.cnki.rao.2017.0232.
58. Kohen MC, Tatlipinar S, Cumbul A, et al. The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury[J]. Mol Vis, 2018, 24: 239-250.
59. Abcouwer SF, Lin C, Shanmugam S, et al. Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury[J]. J Neuroinflammation, 2013, 10(1): 149. DOI: 10.1186/1742-2094-10-149.
60. Mi X, Feng Q, Lo AC, et al. Protection of retinal ganglion cells and retinal vasculature by lycium barbarum polysaccharides in a mouse model of acute ocular hypertension[J/OL]. PLoS One, 2012, 7(10): 45469[2012-10-19]. http://europepmc.org/article/PMC/3477168. DOI: 10.1371/journal.pone.0045469.
61. 张惟, 韩琪, 颜华, 等. 糖尿病视网膜病变大鼠骨髓内皮祖细胞数量和功能变化[J]. 中华眼视光学与视觉科学杂志, 2013, 15(2): 92-97. DOI: 10.3760/cma.j.issn.1674-845X.2013.02.008.Zhang W, Han Q, Yan H, et al. Changes in the number and function of bone marrow endothelial progenitor cells in diabetic retinopathy rats[J]. Chin J Ophthalmol Vis Sci, 2013, 15(2): 92-97. DOI: 10.3760/cma.j.issn.1674-845X.2013.02.008.
62. Li S, Fung FK, Fu Z, et al. Anti-inflammatory effects of lutein inretinal ischemic/hypoxic injury: in vivo and in vitro studies[J]. Invest Ophthalmol Vis Sci, 2012, 53(10): 5976-5984. DOI: 10.1167/iovs.12-10007.
63. 张海江, 梁亮. 姜黄素对视网膜缺血再灌注损伤大鼠视网膜组织结构及IL-23和IL-17表达的影响[J]. 国际眼科杂志, 2017, 17(8): 1423-1426. DOI: 10.3980/j.issn.1672-5123.2017.8.08.Zhang HJ, Liang L. Effects of curcumin on retinal tissue structure and IL-23 and IL-17 expression in rats with retinal ischemia-reperfusion injury[J]. Int Eye Sci, 2017, 17(8): 1423-1426. DOI: 10.3980/j.issn.1672-5123.2017.8.08.

Previous Article
The advances of diabetic retinal neurodegeneration
Next Article
Macular pigment optical density and its relation with fundus disease

Chinese Journal of Ocular Fundus Diseases

Research progress in the mechanism and treatment of retinal ischemia reperfusion injury

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content